Contact
Please use this form to send email to PR contact of this press release:
Opportunity for Patients with Grade 2 Glioma Brain Tumors with IDH1/IDH2 Mutations or Their Caregivers
TO:
Dellann Elliott Mydland
End brain cancer Initiative
+1 425-444-2215